22 November 2017
News and Views
Links and Services
A study in this week's issue of The Lancet investigates daily aspirin and the long-term risk of death due to cancers, including gastrointestinal cancer.
Treatment with daily aspirin for 5 years or longer reduces subsequent risk of colorectal cancer.
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors